Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory Bowel Diseases

Nonadherence to Biologic Therapies in Inflammatory Bowel Disease

(2018) Brian J Wentworth et al.   INFLAMMATORY BOWEL DISEASES

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

(2017) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)

(2017) Carl Eriksson et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab – a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)

(2017) Tero Ylisaukko-oja et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study

(2016) A. Stallmach et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature

(2016) Meaghan Krohe et al.   Patient Preference and Adherence

Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach

(2016) Rieke Alten et al.   Patient Preference and Adherence

Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer

(2016) Brian S. Seal et al.   Journal of Managed Care & Specialty Pharmacy

A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases

(2015) Eleni Vangeli et al.   ADVANCES IN THERAPY

Treatment Nonadherence in Inflammatory Bowel Disease

(2015) Margot L. Herman et al.   INFLAMMATORY BOWEL DISEASES

Vedolizumab Effectiveness and Safety Over the First Year of Use in an IBD Clinical Practice

(2015) Emily E. Vivio et al.   Journal of Crohns & Colitis

Predictors of Self-Reported Adherence to Antihypertensive Medicines: A Multinational, Cross-Sectional Survey

(2015) Valerie L. Morrison et al.   VALUE IN HEALTH

Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland

(2015) Piia K. Rannanheimo et al.   VALUE IN HEALTH

Adherence to Anti-TNF Therapy in Inflammatory Bowel Diseases

(2013) Anthony Lopez et al.   INFLAMMATORY BOWEL DISEASES

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

(2013) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis

(2013) Alesia Sadosky et al.   Patient Preference and Adherence

Adherence, Discontinuation, and Switching of Biologic Therapies in Medicaid Enrollees with Rheumatoid Arthritis

(2010) Pengxiang Li et al.   VALUE IN HEALTH

Factors Associated With Non-Adherence to Oral Medication for Inflammatory Bowel Disease: A Systematic Review

(2009) C A Jackson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prevalence, predictors, and clinical consequences of medical adherence in IBD: How to improve it?

(2009) Peter Laszlo Lakatos   WORLD JOURNAL OF GASTROENTEROLOGY

Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease

(2008) R. PANACCIONE et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS